Modification Of Disease Outcome In COPD

NCT00158847 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: fluticasone 500 mcg
DRUG: fluticasone 500 mcg + salmeterol 50 mcg

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]